Información de Hologic Inc, dividendo de Hologic Inc, actividades de los accionistas y más

Más Datos de Hologic Inc Compañía

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Información de la empresa

Código de la empresaHOLX

Nombre de la empresaHologic Inc

Fecha de salida a bolsaMar 01, 1990

Fundada en1990

Director ejecutivoMr. Stephen P. (Steve) Macmillan

Número de empleados7063

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 01

Dirección250 Campus Drive

CiudadMARLBOROUGH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01752

Teléfono15082632900

Sitio Webhttps://www.hologic.com/

Código de la empresaHOLX

Fecha de salida a bolsaMar 01, 1990

Fundada en1990

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Mr. John M. Griffin

General Counsel

122.84K

+0.07%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

7.06K

+15.71%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

6.16K

-1.44%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Mr. John M. Griffin

General Counsel

122.84K

+0.07%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Desglose de ingresos

Divisa: USDHora de actualización: dom., 6 de abr

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

663.70M

64.95%

Service

198.60M

19.44%

Capital equipment, components and software

154.20M

15.09%

Other

5.30M

0.52%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

757.90M

74.17%

Europe

148.90M

14.57%

Asia

59.80M

5.85%

Rest of World

55.20M

5.40%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

663.70M

64.95%

Service

198.60M

19.44%

Capital equipment, components and software

154.20M

15.09%

Other

5.30M

0.52%

Accionista

Hora de actualización: vie., 21 de feb

Estadísticas de accionistas

Tipo

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

11.94%

T. Rowe Price Investment Management, Inc.

7.99%

BlackRock Institutional Trust Company, N.A.

6.08%

State Street Global Advisors (US)

4.61%

Morgan Stanley Investment Management Ltd. (UK)

3.76%

Other

65.61%

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

11.94%

T. Rowe Price Investment Management, Inc.

7.99%

BlackRock Institutional Trust Company, N.A.

6.08%

State Street Global Advisors (US)

4.61%

Morgan Stanley Investment Management Ltd. (UK)

3.76%

Other

65.61%

Tipo

Accionista

Proporción

Investment Advisor

53.35%

Investment Advisor/Hedge Fund

41.11%

Pension Fund

2.87%

Hedge Fund

2.62%

Research Firm

2.19%

Bank and Trust

1.72%

Sovereign Wealth Fund

0.90%

Individual Investor

0.85%

Family Office

0.05%

Participación institucional

Hora de actualización: lun., 20 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

1568

238.16M

106.14%

-10.52M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

2023Q1

1582

247.98M

100.57%

-12.56M

2022Q4

1556

249.37M

101.43%

-12.38M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

26.79M

11.94%

-54.38K

-0.20%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

17.94M

7.99%

-4.20M

-18.97%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.65M

6.08%

-23.32K

-0.17%

Dec 31, 2024

State Street Global Advisors (US)

10.35M

4.61%

-60.64K

-0.58%

Dec 31, 2024

Morgan Stanley Investment Management Ltd. (UK)

8.44M

3.76%

-455.77K

-5.12%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.73M

2.55%

+144.84K

+2.59%

Dec 31, 2024

Fidelity Management & Research Company LLC

5.15M

2.29%

+82.81K

+1.64%

Dec 31, 2024

Victory Capital Management Inc.

4.92M

2.19%

+24.36K

+0.50%

Dec 31, 2024

Mitsubishi UFJ Asset Management Co., Ltd.

4.40M

1.96%

+129.03K

+3.02%

Dec 31, 2024

Pacer Advisors, Inc.

3.66M

1.63%

+3.57M

+3.88K%

Dec 31, 2024

ETFs relacionados

Hora de actualización: dom., 6 de abr

Nombre

Proporción

First Trust Nasdaq Lux Digi Health Solutions ETF

2.99%

LeaderShares AlphaFactor Tactical Focused ETF

2.84%

VictoryShares THB Mid Cap ESG ETF

2.6%

Formidable ETF

2.13%

Global X US Cash Flow Kings 100 ETF

2.11%

First Trust Capital Strength ETF

1.76%

SPDR S&P Health Care Equipment ETF

1.54%

iShares U.S. Medical Devices ETF

1.53%

First Trust Health Care Alphadex Fund

1.52%

John Hancock Fundamental All Cap Core ETF

1.52%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción2.99%

LeaderShares AlphaFactor Tactical Focused ETF

Proporción2.84%

VictoryShares THB Mid Cap ESG ETF

Proporción2.6%

Formidable ETF

Proporción2.13%

Global X US Cash Flow Kings 100 ETF

Proporción2.11%

First Trust Capital Strength ETF

Proporción1.76%

SPDR S&P Health Care Equipment ETF

Proporción1.54%

iShares U.S. Medical Devices ETF

Proporción1.53%

First Trust Health Care Alphadex Fund

Proporción1.52%

John Hancock Fundamental All Cap Core ETF

Proporción1.52%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Hologic Inc

58.360USD

Hologic Inc

58.360

Descripción general

Compañía